The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF

RecruitingOBSERVATIONAL
Enrollment

1,000,000

Participants

Timeline

Start Date

February 18, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

December 31, 2025

Conditions
Heart FailureMortality
Interventions
DRUG

Angiotensin receptor neprilysin inhibitor (ARNI)

The group with ARNI was defined as patients with HFrEF took ARNI more than 3 months

DRUG

Renin-Angiotensin System Inhibitor (RAS inhibitor)

The group with RAS inhibitor was defined as patients with HFrEF took RAS inhibitor more than 3 months

Trial Locations (1)

26426

RECRUITING

Yonsei University Wonju College of Medicine, Wŏnju

All Listed Sponsors
lead

Wonju Severance Christian Hospital

OTHER